Alf Meem Yaa for Medical Supplies and Equipment Company (TADAWUL:9527)
70.30
+1.20 (1.74%)
Sep 3, 2026, 3:10 PM AST
TADAWUL:9527 Ratios and Metrics
Market cap in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 492 | 665 | 886 | 351 | 244 | - | |
Market Cap Growth | -42.33% | -24.96% | 152.19% | 43.84% | - | - |
Enterprise Value | 496 | 666 | 879 | 328 | 238 | - |
Last Close Price | 70.30 | 92.44 | 120.94 | 46.35 | 30.88 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 14.60 | 19.00 | 19.52 | 10.49 | 9.15 | - |
Forward PE | - | 13.34 | - | - | - | - |
PS Ratio | 1.57 | 2.18 | 3.57 | 1.60 | 1.26 | - |
PB Ratio | 2.56 | 3.71 | 5.58 | 2.76 | 2.28 | - |
P/TBV Ratio | 2.59 | 3.76 | 5.63 | 2.76 | 2.28 | - |
P/FCF Ratio | - | - | - | 10.12 | 32.33 | - |
P/OCF Ratio | - | - | - | 9.59 | 29.19 | - |
PEG Ratio | - | 0.45 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.58 | 2.19 | 3.54 | 1.49 | 1.23 | - |
EV/EBITDA Ratio | 12.04 | 15.47 | 17.56 | 8.80 | 7.95 | - |
EV/EBIT Ratio | 12.32 | 15.76 | 17.82 | 8.90 | 8.02 | - |
EV/FCF Ratio | - | - | - | 9.44 | 31.56 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | - | 0.16 | 0.01 | 0.02 | 0.01 | 0.02 |
Debt / EBITDA Ratio | - | 0.64 | 0.03 | 0.07 | 0.04 | 0.06 |
Debt / FCF Ratio | - | - | - | 0.08 | 0.15 | 0.08 |
Net Debt / Equity Ratio | - | 0.10 | -0.14 | -0.32 | -0.21 | -0.29 |
Net Debt / EBITDA Ratio | - | 0.42 | -0.45 | -1.09 | -0.74 | -1.10 |
Net Debt / FCF Ratio | - | -0.67 | 5.79 | -1.17 | -2.94 | -1.35 |
Asset Turnover | - | 1.21 | 1.18 | 1.28 | 1.34 | 1.28 |
Inventory Turnover | - | 1.93 | 2.46 | 2.73 | 2.88 | 3.48 |
Quick Ratio | - | 1.84 | 2.46 | 2.54 | 2.69 | 3.06 |
Current Ratio | - | 3.28 | 3.77 | 3.53 | 4.06 | 4.10 |
Return on Equity (ROE) | - | 20.71% | 31.75% | 28.58% | 26.58% | 27.04% |
Return on Assets (ROA) | - | 10.49% | 14.69% | 13.36% | 12.89% | 12.92% |
Return on Invested Capital (ROIC) | - | 22.92% | 40.21% | 38.31% | 34.84% | 35.66% |
Return on Capital Employed (ROCE) | - | 21.90% | 28.90% | 26.70% | 25.40% | 24.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 6.85% | 5.26% | 5.12% | 9.54% | 10.92% | - |
FCF Yield | -1.35% | -4.03% | -0.44% | 9.88% | 3.09% | - |
Dividend Yield | 2.85% | 2.16% | 1.65% | 4.32% | 6.48% | - |
Payout Ratio | 0.04% | 39.99% | 30.81% | 41.74% | 45.91% | 7.54% |
Buyback Yield / Dilution | -0.03% | - | - | - | -0.65% | -21.22% |
Total Shareholder Return | 2.81% | 2.16% | 1.65% | 4.32% | 5.83% | -21.22% |